Skip to content

News releases

The following are news releases and statements issued by Biosimilars Canada. News stories about biosimilars that may be of interest to readers are available here.

#SaveBigWithBiosimilars Campaign Provides Sustainable Solutions for Employer-Sponsored Health Benefit Plans

Toronto – November 14, 2024 – Biosimilars Canada has launched a new #SaveBigWithBiosimilars campaign to educate Canadian businesses about the benefits of adopting biosimilar transition policies for their employee health benefit plans. While public drug programs across Canada have adopted...
Read more

Manitoba Announces Transition to Cost-Saving Biosimilar Medicines

All Ten Canadian Provinces Have Now Made the Switch to Biosimilars Toronto – August 6, 2024 – Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, welcomes the announcement by the Government of Manitoba that it has implemented a...
Read more

Biosimilars Canada Announces Re-Election of Board Chair and Vice-Chair

Toronto – May 7, 2024 – Biosimilars Canada is pleased to announce the unanimous re-election of Mr. Mike Woolcock, Senior Vice President of Biosimilars and Specialty Products with Apotex, as Chair of the Biosimilars Canada Board. Mr. Mike Casia, President...
Read more

CGPA and Biosimilars Canada Statement on Proposed Pharmacare Legislation

The generic and biosimilar medicines industries will need to learn more about the Government of Canada’s approach to implementation, and consult with key stakeholders, to help ensure that a transition to this program would maximize the use of cost-saving generic and biosimilar medicines, while protecting Canada’s drug supply and domestic manufacturing capacity.
Read more

PEI Announces Transition to Cost-Saving Biosimilar Medicines

Toronto – October 12, 2023 – Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, welcomes the announcement by the Government of Prince Edward Island (PEI) that it is implementing a “switching” or transitioning policy to expand the use...
Read more

Yukon Announces Transition to Cost-Saving Biosimilar Medicines

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today welcomed the announcement by the Yukon Government that it is implementing a “switching” or transitioning policy to expand the use of biosimilar biologic medicines for its public drug programs.
Read more
1 2 3 6